End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.72 CNY | +1.35% | -2.53% | -5.55% |
Jun. 05 | Hengrui Pharma Units Get China Nod for Clinical Trial of Tumor Drug | MT |
May. 30 | Hengrui Pharmaceuticals Gets Nod to Trial Vitiligo Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.55% | 36.98B | |
+48.53% | 779B | |
+40.67% | 631B | |
-6.37% | 354B | |
+20.93% | 333B | |
+8.21% | 301B | |
+16.75% | 249B | |
-1.19% | 216B | |
+10.85% | 214B | |
+4.40% | 163B |
- Stock Market
- Equities
- 600276 Stock
- News Jiangsu Hengrui Medicine Co., Ltd.
- Hengrui Pharmaceuticals to Resubmit Marketing Application for Liver Cancer Drug Combination to US FDA